Volume 25, Issue 1 (Apr - May 2021)
2021, 25(1): 19-24 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Esmaeili M H, Sofiabadi M, Afshar A. The Effects of Prenatal Norharman Exposure on Seizure Severity in Rats. Journal of Inflammatory Diseases. 2021; 25 (1) :19-24
URL: http://journal.qums.ac.ir/article-1-3149-en.html
URL: http://journal.qums.ac.ir/article-1-3149-en.html
1- Department of Physiology, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
2- Department of Physiology, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran. , mohasofi@yahoo.com
2- Department of Physiology, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran. , mohasofi@yahoo.com
Abstract: (1138 Views)
Background: Norhraman is an alkaloid that can damage the nervous system.
Objective: This experimental study aimed to investigate the effects of prenatal norharman exposure on seizure severity in adult rats.
Methods: A total of 36 Wistar rats were randomly divided into 3 groups as follows: Control, sham (solvent), and norharman (1000 ug/kg). The sham and norharman groups were treated once daily for 8-18 of the fetal period. 2 months after birth, kindling was performed by the daily injection of Pentylenetetrazol (PTZ) (30 mg/kg); then, the seizure behavior was recorded for approximately 30 minutes. The obtained data were analyzed using Analysis of Variance (ANOVA) and Tukey’s posthoc test.
Results: The present study data indicated that administrating norharman in the fetal period increased seizure responses to PTZ, i.e., significant in the examined female rats (P<0.05).
Conclusion: According to the current research findings, the severity of seizures increases in subjects who have been exposed to norharman during the prenatal period.
Objective: This experimental study aimed to investigate the effects of prenatal norharman exposure on seizure severity in adult rats.
Methods: A total of 36 Wistar rats were randomly divided into 3 groups as follows: Control, sham (solvent), and norharman (1000 ug/kg). The sham and norharman groups were treated once daily for 8-18 of the fetal period. 2 months after birth, kindling was performed by the daily injection of Pentylenetetrazol (PTZ) (30 mg/kg); then, the seizure behavior was recorded for approximately 30 minutes. The obtained data were analyzed using Analysis of Variance (ANOVA) and Tukey’s posthoc test.
Results: The present study data indicated that administrating norharman in the fetal period increased seizure responses to PTZ, i.e., significant in the examined female rats (P<0.05).
Conclusion: According to the current research findings, the severity of seizures increases in subjects who have been exposed to norharman during the prenatal period.
Type of Study: Research |
Subject:
Physiology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Contact Information
Journal of Inflammatory Diseases
Shahid Bahonar Blvd, Qazvin University of Medical Sciences, Qazvin, Iran
Shahid Bahonar Blvd, Qazvin University of Medical Sciences, Qazvin, Iran
Journal Tel: +98 28 33357036
Website: http://journal.qums.ac.ir
E-mail: jresearchdpt@qums.ac.ir
